Can defibrotide prophylaxis prevent sinusoidal obstruction syndrome following haematopoietic stem-cell transplantation?

Lancet Haematol. 2023 May;10(5):e309-e311. doi: 10.1016/S2352-3026(23)00065-0. Epub 2023 Mar 28.

Authors

Niketa C Shah¹, Shalini Shenoy²

Affiliations

¹ Pediatric Stem cell Transplant Program, Section of Pediatric Hematology and Oncology, Yale School of Medicine, Yale University, New Haven, CT 06510, USA. Electronic address: Niketa.shah@yale.edu.
² Pediatric Stem cell transplant Program, St Louis Children's Hospital Washington University, St Louis, MO, USA.

PMID: 37001535
DOI: 10.1016/S2352-3026(23)00065-0

No abstract available

Publication types

Comment

MeSH terms

Hematopoietic Stem Cell Transplantation* / adverse effects
Hepatic Veno-Occlusive Disease* / drug therapy
Hepatic Veno-Occlusive Disease* / etiology
Hepatic Veno-Occlusive Disease* / prevention & control
Humans
Polydeoxyribonucleotides / therapeutic use

Substances

defibrotide
Polydeoxyribonucleotides